These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11435815)

  • 21. [Clinical symptoms, diagnosis and treatment of multiple endocrine neoplasia type 1. Results of genetic screening in Hungarian patients].
    Balogh K; Hunyady L; Patócs A; Valkusz Z; Bertalan R; Gergics P; Majnik J; Toke J; Tóth M; Szucs N; Gláz E; Futo L; Horányi J; Rácz K; Tulassay Z
    Orv Hetil; 2005 Oct; 146(43):2191-7. PubMed ID: 16323565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural course of small adrenal lesions in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study.
    Schaefer S; Shipotko M; Meyer S; Ivan D; Klose KJ; Waldmann J; Langer P; Kann PH
    Eur J Endocrinol; 2008 May; 158(5):699-704. PubMed ID: 18426829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial risk for neuroendocrine tumors.
    Anderson RJ; Lynch HT
    Curr Opin Oncol; 1993 Jan; 5(1):75-84. PubMed ID: 8094015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of an MEN1 gene mutation depends on clinical features and supports current referral criteria for diagnostic molecular genetic testing.
    Ellard S; Hattersley AT; Brewer CM; Vaidya B
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):169-75. PubMed ID: 15670192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.
    Dreijerink KM; Höppener JW; Timmers HM; Lips CJ
    Nat Clin Pract Endocrinol Metab; 2006 Oct; 2(10):562-70. PubMed ID: 17024155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pathologic study with immunohistochemistry of 61 pancreatic endocrine tumors in 16 patients suffering from multiple endocrine neoplasia type I (MEN I). Review of the literature].
    Heymann MF; Moreau A; Chetritt J; Murat A; Leborgne J; Le Neel JC; Visset J; Le Bodic MF
    Ann Pathol; 1996; 16(3):167-73. PubMed ID: 8766173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Adrenal lesions in patients of multiple endocrine neoplasia type 1].
    Zhu Y; Zhang HB; Lu L; Li NS; Fu Y; Wang O; Xu LL; Jiang Y; Tong AL; Zhu HJ; Li W; Hu MM; Yu M; Mao JF; Yuan T; Li M; Xia WB; Xing XP
    Zhonghua Yi Xue Za Zhi; 2010 Oct; 90(38):2689-92. PubMed ID: 21162898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple endocrine neoplasia type 1: clinical and genetic features.
    Skogseid B; Doherty GM
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S131-4. PubMed ID: 10604116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Multiple endocrine neoplasia type I. Review and presentation of the study group of multiple endocrine neoplasia type I (GENEM I)].
    Saint-André JP; Berger-Dutrieux N; Le Bodic MF; de Micco C; Trouillas J
    Arch Anat Cytol Pathol; 1994; 42(2):77-82. PubMed ID: 7811118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulinomatosis: a multicentric insulinoma disease that frequently causes early recurrent hyperinsulinemic hypoglycemia.
    Anlauf M; Bauersfeld J; Raffel A; Koch CA; Henopp T; Alkatout I; Schmitt A; Weber A; Kruse ML; Braunstein S; Kaserer K; Brauckhoff M; Dralle H; Moch H; Heitz PU; Komminoth P; Knoefel WT; Perren A; Klöppel G
    Am J Surg Pathol; 2009 Mar; 33(3):339-46. PubMed ID: 19011561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical characteristics of pheochromocytoma patients with germline mutations in SDHD.
    Dannenberg H; van Nederveen FH; Abbou M; Verhofstad AA; Komminoth P; de Krijger RR; Dinjens WN
    J Clin Oncol; 2005 Mar; 23(9):1894-901. PubMed ID: 15774781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No evidence of somatic aryl hydrocarbon receptor interacting protein mutations in sporadic endocrine neoplasia.
    Raitila A; Georgitsi M; Karhu A; Tuppurainen K; Mäkinen MJ; Birkenkamp-Demtröder K; Salmenkivi K; Orntoft TF; Arola J; Launonen V; Vahteristo P; Aaltonen LA
    Endocr Relat Cancer; 2007 Sep; 14(3):901-6. PubMed ID: 17914118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endocrine precursor lesions and microadenomas of the duodenum and pancreas with and without MEN1: criteria, molecular concepts and clinical significance.
    Anlauf M; Perren A; Klöppel G
    Pathobiology; 2007; 74(5):279-84. PubMed ID: 17890894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of multiple endocrine neoplasia type 1 in patients with apparent sporadic primary hyperparathyroidism.
    Yip L; Ogilvie JB; Challinor SM; Salata RA; Thull DL; Yim JH; Carty SE
    Surgery; 2008 Dec; 144(6):1002-6; discussion 1006-7. PubMed ID: 19041010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adrenal involvement in multiple endocrine neoplasia type 1: results of 7 years prospective screening.
    Waldmann J; Bartsch DK; Kann PH; Fendrich V; Rothmund M; Langer P
    Langenbecks Arch Surg; 2007 Jul; 392(4):437-43. PubMed ID: 17235589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Multiple endocrine neoplasia type I].
    Koncz E; Schmid KW
    Pathologe; 2010 Oct; 31(6):445-8. PubMed ID: 20960195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for multiple endocrine neoplasia type 1 and hormonal production in apparently sporadic neuroendocrine tumors.
    Baudin E; Bidart JM; Rougier P; Lazar V; Ruffié P; Ropers J; Ducreux M; Troalen F; Sabourin JC; Comoy E; Lasser P; DeBaere T; Schlumberger M
    J Clin Endocrinol Metab; 1999 Jan; 84(1):69-75. PubMed ID: 9920064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting the risk of multiple endocrine neoplasia type 1 for patients with commonly occurring endocrine tumors.
    de Laat JM; Tham E; Pieterman CR; Vriens MR; Dorresteijn JA; Bots ML; Nordenskjöld M; van der Luijt RB; Valk GD
    Eur J Endocrinol; 2012 Aug; 167(2):181-7. PubMed ID: 22581216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d'etude des Tumeurs Endocrines.
    Goudet P; Bonithon-Kopp C; Murat A; Ruszniewski P; Niccoli P; Ménégaux F; Chabrier G; Borson-Chazot F; Tabarin A; Bouchard P; Cadiot G; Beckers A; Guilhem I; Chabre O; Caron P; Du Boullay H; Verges B; Cardot-Bauters C
    Eur J Endocrinol; 2011 Jul; 165(1):97-105. PubMed ID: 21551167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How should the patient with multiple endocrine neoplasia type 1 (MEN 1) be followed?
    Burgess J
    Clin Endocrinol (Oxf); 2010 Jan; 72(1):13-6. PubMed ID: 19552677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.